Based on these findings, we have demonstrated that CrF‐EVs have significant beneficial roles in improving lymphatic functions and alleviating colitis and mesenteritis via the miR‐132‐3p/RASA1/ERK1/2 axis. Here, MAPK3 is linked to colitis.